|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Pharm Exec's 15th Annual Industry Auditover 9 years ago
The Industry Audit: Fifteen Years Rightover 9 years ago
Dealmaking in 2016: It’s Complicatedover 9 years ago
Steady Hands: AmerisourceBergen's Peyton Howellover 9 years ago
Drug Shortages Raise Economic and Ethical Challengesover 9 years ago
The ‘Cure’-All for 21st Century Data Sharingover 9 years ago
European Pharma and the Unified Patent Courtover 9 years ago
An EU Referendum ... on Drug Pricing?over 9 years ago
Country Report: HungaryNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
